The enteral nutrition market involves products that provide nutrition to patients who cannot swallow or digest food through the gastrointestinal tract. The demand for tube feeding formulas, administration sets, and enteral feeding pumps is growing owing to the increasing prevalence of chronic diseases such as cancer and gastrointestinal disorders.

The global enteral nutrition market is estimated to be valued at US$ 8.7 billion in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Enteral Nutrition Companies are Abbott Nutrition, B.Braun Melsungen AG, Danone Nutricia, Cardinal Health, Nestlé Health Science. These players are focusing on new product launches and expansion strategies to strengthen their market position.

The Enteral Nutrition Market Demand include growing demand from homecare facilities and increasing awareness about clinical benefits of enteral feeding. The market is also driven by expanding healthcare infrastructure and improving reimbursement policies in developing regions.

Globally, the market is expanding due to rising geriatric population suffering from chronic diseases. The Asia Pacific region presents lucrative prospects for enteral nutrition companies owing to improving healthcare standards and growing medical tourism in countries like India and China.

Market Drivers

Rising prevalence of Enteral Nutrition Companies disorders requiring enteral feeding is a major growth driver for this market. According to WHO, chronic diseases accounted for 71% of global deaths in 2019. Enteral nutrition is often recommended for disease management as it reduces complications and improves outcomes. The growing geriatric population globally, which is more vulnerable to chronic illnesses, will further propel the demand for enteral feeding solutions in the coming years.

Get More Insights On, Enteral Nutrition Market